Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Ovarian Neoplasms

Free Subscription 07.05.2012 1 Ann Oncol 2 Br J Cancer 1 Cancer Lett 2 Cancer Res 3 Clin Cancer Res 5 Eur J Gynaecol Oncol 5 Gynecol Oncol 1 Int J Oncol 1 J Clin Oncol 3 Lancet Oncol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Oncol

1. LINDEMANN K , Christensen RD, Vergote I, Stuart G, et al
   First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.
   Ann Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Br J Cancer

2. SIMS AH , Zweemer AJ, Nagumo Y, Faratian D, et al
   Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer.
   Br J Cancer. 2012 May 1. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. STALBERG K , Svensson T, Granath F, Kieler H, et al
   Evaluation of prevalent and incident ovarian cancer co-morbidity.
   Br J Cancer. 2012 May 1. doi: 10.1038/bjc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Cancer Lett

4. SCHAFER H , Dieckmann C, Korniienko O, Moldenhauer G, et al
   Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Cancer Res

5. MATEI D , Fang F, Shen C, Schilder J, et al
   Epigenetic Resensitization to Platinum in Ovarian Cancer.
   Cancer Res. 2012;72:2197-2205.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. BAI L , McEachern D, Yang CY, Lu J, et al
   LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFalpha expression and receptor tyrosine kinase signaling.
   Cancer Res. 2012;72:1229-38.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Clin Cancer Res

7. NIELSEN JS , Sahota RA, Milne K, Kost SE, et al
   CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
   Clin Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. HUNTER SM , Anglesio MS, Sharma R, Gilks B, et al
   Copy number aberrations in benign serous ovarian tumors: a case for reclassification?
   Clin Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. WU R , Hu T, Rehemtulla A, Fearon ER, et al
   Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma.
   Clin Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Eur J Gynaecol Oncol

10. ZAMUROVIC M , Pesic-Stevanovic I
    Rare metastases of pancreatic tail carcinoma in female genital organs.
    Eur J Gynaecol Oncol. 2012;33:116-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. MENON PA , Kousparos G, Culora GA
    Primary gynaecological tumours mistaken for metastases: report of two cases with review of literature.
    Eur J Gynaecol Oncol. 2012;33:109-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. D'IPPOLITO G , Huizing MT, Tjalma WA
    Desmoplastic small round cell tumor (DSRCT) arising in the ovary: report of a case diagnosed at an early stage and review of the literature.
    Eur J Gynaecol Oncol. 2012;33:96-100.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. CHENG X , Cheng B, Wan X, Lu W, et al
    Outcomes of conservative surgery in early epithelial ovarian carcinoma.
    Eur J Gynaecol Oncol. 2012;33:93-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. ALANBAY I , Akturk E, Coksuer H, Ercan CM, et al
    Comparison of tumor markers and clinicopathological features in serous and mucinous borderline ovarian tumors.
    Eur J Gynaecol Oncol. 2012;33:25-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Gynecol Oncol

15. PEIRETTI M , Bristow RE, Zapardiel I, Gerardi M, et al
    Recto-sigmoid resection at the time of primary cytoreduction for advanced ovarian cancer: A multi-center analysis of surgical and oncological outcomes.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. HYNNINEN J , Auranen A, Carpen O, Dean K, et al
    FDG PET/CT in staging of advanced epithelial ovarian cancer: Frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. ZHANG X , Samadi AK, Roby KF, Cohen MS, et al
    Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. VISHNU P , Colon-Otero G, Kennedy GT, Marlow LA, et al
    RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. GARCIA AA , Sill MW, Lankes HA, Godwin AK, et al
    A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Int J Oncol

20. ZGHEIB NB , Xiong Y, Marchion DC, Bicaku E, et al
    The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer.
    Int J Oncol. 2012 Apr 26. doi: 10.3892/ijo.2012.1451.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Clin Oncol

21. JANKU F , Wheler JJ, Westin SN, Moulder SL, et al
    PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
    J Clin Oncol. 2012;30:777-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Lancet Oncol

22. PEARCE CL , Berchuck A
    Endometriosis and ovarian cancer - Authors' reply.
    Lancet Oncol. 2012;13:e190.
    PubMed     Text format     Related articles   
    
    
    
23. GUO SW , Zilberberg MD, Hummelshoj L
    Endometriosis and ovarian cancer.
    Lancet Oncol. 2012;13:e189-90.
    PubMed     Text format     Related articles   
    
    
    
24. VERCELLINI P , Somigliana E, Buggio L, Bolis G, et al
    Endometriosis and ovarian cancer.
    Lancet Oncol. 2012;13:e188-9.
    PubMed     Text format     Related articles   
    
    
    

    
    PLoS One

25. PETRUCCI E , Pasquini L, Bernabei M, Saulle E, et al
    A Small Molecule SMAC Mimic LBW242 Potentiates TRAIL- and Anticancer Drug-Mediated Cell Death of Ovarian Cancer Cells.
    PLoS One. 2012;7:e35073.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: